News In blink-and-miss-it moment, Harris vows to expand OOP cap The US Presidential debate barely mentioned pharma topics, but Harris did have one notable sound bite toward the very end of the night.
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.